The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Donafenib combined with anti-PD-1 antibody and transarterial chemoembolization (TACE) as first-line (1L) treatment for unresectable/advanced hepatocellular carcinoma (HCC).
 
Jian Zhou
No Relationships to Disclose
 
Zhiping Yan
No Relationships to Disclose
 
Zheng Wang
No Relationships to Disclose
 
Shuang-Jian Qiu
No Relationships to Disclose
 
Minjie Yang
No Relationships to Disclose
 
Kai Zhu
No Relationships to Disclose
 
Yong Yi
No Relationships to Disclose
 
Lei Yu
No Relationships to Disclose
 
Yun-Fan Sun
No Relationships to Disclose
 
Bo Zhang
No Relationships to Disclose
 
Jiaze Yu
No Relationships to Disclose